Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

ACWY Vax to be discontinued

The manufacturer of ACWY Vax (meningococcal polysaccharide groups ACW135Y vaccine) has written to healthcare professionals advising that this product is being discontinued in the UK. It is expected that stocks will be exhausted by June 2014.

The letter notes that two alternative conjugate vaccines that contain the same A, C, W135 and Y strains are available but also notes that the licensed indications may differ. The brand names for these products are Menveo® and Nimenrix®.

Action: Clinicians who currently use ACWY Vax should be aware of this product being discontinued and make themselves familiar with the alternatives.

Share 'ACWY Vax to be discontinued' on Email Share 'ACWY Vax to be discontinued' on Delicious Share 'ACWY Vax to be discontinued' on Digg Share 'ACWY Vax to be discontinued' on Facebook Share 'ACWY Vax to be discontinued' on Google+ Share 'ACWY Vax to be discontinued' on reddit Share 'ACWY Vax to be discontinued' on StumbleUpon Share 'ACWY Vax to be discontinued' on Twitter

atomic-wealth

No Comments to “ACWY Vax to be discontinued”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,599 spam comments.

atomic-wealth
fond-illness
summer